Disease Management in Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 15, Issue 1, 2008, Pages 19-28

  Rastogi, Anjay ^a   Linden, Ariel ^a   Nissenson, Allen R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease; Disease management; Disease management organization; End stage renal disease; Medicare

Indexed keywords

ARTICLE; AWARENESS; CAREGIVER; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; DIALYSIS; DISEASE COURSE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MEDICAL SPECIALIST; MEDICARE; NEPHROLOGIST; ORGANIZATION; OUTCOME ASSESSMENT; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED STATES;

CHRONIC DISEASE; DISEASE MANAGEMENT; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MEDICARE; PATIENT CARE TEAM; PROGRAM EVALUATION; RENAL REPLACEMENT THERAPY; UNITED STATES;

EID: 37449008843     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2007.10.011     Document Type: Article

References (37)

1. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
2. Nissenson A.R., Collins A.J., Dickmeyer J., et al. Medical Advisory Board, RMS Disease Management, Inc. Evaluation of disease-state management of dialysis patients. Am J Kidney Dis 37 (2001) 938-944 (erratum in Am J Kidney Dis 38:701, 2001)
3. Licht M., Crooks P., Donald L., et al. Progress in renal disease management: Optimal Renal Care. Nephrol News Issues 15 (2001) 21-27
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39 (2002) S1-S266 (suppl 1)
5. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42 (2003) 1050-1065
6. Jungers P., Zingraff J., Page B., et al. Detrimental effects of late referral in patients with chronic renal failure: A case-control study. Kidney Int Suppl 41 (1993) S170-S173
7. Obrador G.T., and Pereira B.J. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31 (1998) 398-417
8. Winkelmayer W.C., Owen Jr. W.F., Levin R., et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 14 (2003) 486-492
9. U.S. Renal Data System. USRDS 2004 annual data report: Atlas of end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2005), USRDS, Bethesda, MD
10. St Peter W.L., Khan S.S., Ebben J.P., et al. Chronic kidney disease: The distribution of health care dollars. Kidney Int 66 (2004) 313-321
11. Trivedi H.S., Pang M.M., Campbell A., et al. Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives. Am J Kidney Dis 39 (2002) 721-729
12. Nissenson A.R., Collins A.J., Hurley J., et al. Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 12 (2001) 1713-1720
13. Remuzzi G., Ruggenenti P., Perna A., et al., RENAAL Study Group. Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results. J Am Soc Nephrol 15 (2004) 3117-3125
14. Disease Management Association of America. Available at: http://www.dmaa.org/dm_definition.asp. Accessed November 27, 2007
15. Campbell D.T., and Stanley J.C. Experimental and Quasi-experimental Designs for Research (1966), Rand McNally College Publishing, Chicago, IL
16. Cook T.D., and Campbell D.T. Quasi-experimentation: Design and Analysis Issues for Field Settings (1979), Rand McNally College Publishing, Chicago, IL
17. Shadish S.R., Cook T.D., and Campbell D.T. Experimental and Quasi-experimental Designs for Generalized Causal Inference (2002), Houghton Mifflin, Boston, MA
18. Linden A., Adams J., and Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manag 6 (2003) 93-102
19. Linden A., and Roberts N. A users guide to the disease management literature: Recommendations for reporting and assessing program outcomes. Am J Manag Care 11 (2005) 81-90
20. Linden A. Estimating the effect of regression to the mean in health management programs. Dis Manag Healt Outc 15 (2007) 7-12
21. Linden A., Adams J., and Roberts N. Evaluating disease management program effectiveness: An introduction to time series analysis. Dis Manag 6 (2003) 243-255
22. Linden A., Adams J., and Roberts N. Evaluating disease management program effectiveness: An introduction to the regression-discontinuity design. J Eval Clin Pract 12 (2006) 124-131
23. Linden A., Adams J., and Roberts N. Using propensity scores to construct comparable control groups for disease management program evaluation. Dis Manag Healt Outc 13 (2005) 107-127
24. Linden A., and Adams J. Evaluating disease management program effectiveness: an introduction to instrumental variables. J Eval Clin Pract 12 (2006) 148-154
25. Linden A., Adams J., and Roberts N. Evaluating disease management program effectiveness: An introduction to survival analysis. Dis Manage 7 (2004) 180-190
26. Ware J.E., and Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
27. Rabin R., and de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 33 (2001) 337-343
28. Public Health Division: Report on the 1997 and 1998 NSW Health Surveys. Sydney, NSW Health Department, 2000. Available at: http://www.health.nsw.gov.au/public-health/hs98/euroqol_intro.htm. Accessed November 27, 2007
29. Spertus J.A., Winder J.A., Dewhurst T.A., et al. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 25 (1995) 333-341
30. Green C.P., Porter C.B., Bresnahan D.R., et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. J Am Coll Cardiol 35 (2000) 1245-1255
31. Boyer J.G., and Earp J.A. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care 35 (1997) 440-453
32. Hays R.D., Kallich J.D., Mapes D.L., et al. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3 (1994) 329-338
33. Linden A. What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. Am J Manage Care 12 (2006) 217-222
34. Crooks P. The first ESRD managed care demonstration project: A Kaiser Permanente view. Nephrol News Issues 17 (2003) 29-31 34-5
35. Reynolds L., and Geronemus R. A perspective on the Florida ESRD Demonstration Project. Nephrol News Issues 18 (2004) 58, 60, 62
36. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
37. Obrador G.T., Ruthazer R., Arora P., et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10 (1999) 1793-1800